| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 10/17/2001 | EP1144626A2 Methods of monitoring hiv drug resistance |
| 10/17/2001 | EP1144624A2 Human and mouse trek-1 potassium channel protein and their use |
| 10/17/2001 | EP1144613A1 Methods for making proteins containing free cysteine residues |
| 10/17/2001 | EP1144611A2 Method for recombinant protein production in mammalian cells comprising co-expression with fetuin |
| 10/17/2001 | EP1144600A2 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 10/17/2001 | EP1144595A2 Platform for the differentiation of cells |
| 10/17/2001 | EP1144593A1 Compositions isolated from plant cells and their use in the modification of plant cell signaling |
| 10/17/2001 | EP1144454A2 Modified peptides as therapeutic agents |
| 10/17/2001 | EP1144447A2 Tuberculosis diagnostic test |
| 10/17/2001 | EP1144092A1 Integrated portable biological detection system |
| 10/17/2001 | EP1143985A2 Use of lactobacillus salivarius |
| 10/17/2001 | EP1143797A1 Methods for reducing adverse side effects associated with cellular transplantation |
| 10/17/2001 | EP1113817A4 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies |
| 10/17/2001 | EP0873405A4 Expression augmenting sequence elements (ease) for eukaryotic expression systems |
| 10/17/2001 | EP0792367B1 A dna construct encoding the yap3 signal peptide |
| 10/17/2001 | EP0692025B1 Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
| 10/17/2001 | EP0617706B1 Multivalent antigen-binding proteins |
| 10/17/2001 | EP0471056B1 Biosynthesis of carotenoids in genetically engineered hosts |
| 10/17/2001 | CN1318106A Uracile permease from arabidopsis as herbicidal target gene |
| 10/17/2001 | CN1318070A Modified i(E.coli) enterotoxin II signal peptide and microorganism expressing fusion protein of said peptide and heterologous protein |
| 10/17/2001 | CN1317569A Method for preparing mammal cell kinetin synthetic inhibitory factor |
| 10/17/2001 | CN1317568A Method for producing L-phenylalanine |
| 10/17/2001 | CN1317560A Bleaching compsn. contg. protein enzyme |
| 10/17/2001 | CN1317343A Pharmaceutical Application of mammal cell kinetin synthetic inhibitory factor |
| 10/17/2001 | CN1073159C Human kunitz-type protease inhibitors and its related method |
| 10/17/2001 | CN1073156C Deaminoneuraminidase and process for producing same |
| 10/17/2001 | CN1073154C Superoxide dismutase-4 |
| 10/17/2001 | CN1073118C Diagnostics virus of hepatitis C |
| 10/17/2001 | CN1073115C WS7622A mono-or di-sulfate process for prepn. thereof |
| 10/16/2001 | US6303847 Nucleotide sequence; for transgenic plants |
| 10/16/2001 | US6303769 Lerk-5 dna |
| 10/16/2001 | US6303753 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 10/16/2001 | US6303571 To screen for antibacterial compounds; genetic immunization; therapy and prophylaxis |
| 10/16/2001 | US6303383 Temperature sensitive plasmid for coryneform bacteria |
| 10/16/2001 | US6303382 Formation of and methods for the production of large bacillus thuringiensis crystals with increased pesticidal activity |
| 10/16/2001 | US6303381 Nucleotide sequences; for use as tools in genetic analysis |
| 10/16/2001 | US6303377 Biotin biosynthesis in bacillus subtilis |
| 10/16/2001 | US6303369 Plasmid for generating preferential polypeptides; for use as a tool in genetic engineering |
| 10/16/2001 | US6303358 Enzymatic polypeptide for use in the treatment of alzheimer's neuropathies, and diabetes |
| 10/16/2001 | US6303357 L-α-glycerophosphate oxidase gene, recombinant DNA, and method for producing modified L-α-glycerophosphate oxidase gene |
| 10/16/2001 | US6303354 Fermentation; removal of isatin or indirubin by enzyme; by-product inhibition |
| 10/16/2001 | US6303353 Generation of preferential sugar alchol; incubate arabitol with a microorganism, recover sugar alchol |
| 10/16/2001 | US6303348 DNA coding for protein which confers on bacterium escherichia coli resistance to L-homoserine and method for producing L-amino acids |
| 10/16/2001 | US6303346 Method of producing saccharide preparations |
| 10/16/2001 | US6303342 Recombinant methods and materials for producing epothilones C and D |
| 10/16/2001 | US6303341 Genetically engineered antibody for use in immunotherapy |
| 10/16/2001 | US6303334 Nucleotide sequences coding polypeptides for use in as a viricide and in gene therapy |
| 10/16/2001 | US6303331 Vertebrate apoptosis gene: compositions and methods |
| 10/16/2001 | US6303329 Generation of active human capase; pass solution of protein through matrix, concentrate protein, activate proenzyme |
| 10/16/2001 | US6303151 Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment |
| 10/16/2001 | US6303128 Method for protein expression |
| 10/16/2001 | CA2176236C Tyrosinase-activator protein fusion enzyme |
| 10/16/2001 | CA2087969C Protease resistant pdgf and methods of use |
| 10/16/2001 | CA2044626C Type a platelet-derived growth factor receptor gene |
| 10/16/2001 | CA2031164C Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
| 10/16/2001 | CA2001774C Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 10/16/2001 | CA1341305C Dna binding proteins including androgen receptor |
| 10/14/2001 | CA2344183A1 Glycoprotein having inhibitory activity against helicobacter pylori colonization |
| 10/11/2001 | WO2001075174A2 Detection and typing of human papillomavirus using pna probes |
| 10/11/2001 | WO2001075135A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
| 10/11/2001 | WO2001075077A2 Isolation and expression of a gene for a nitrilase from acidovorax facilis 72w |
| 10/11/2001 | WO2001075070A1 Cell culturing method and device |
| 10/11/2001 | WO2001074772A1 Chemokine receptor antagonists |
| 10/11/2001 | WO2001049865A8 Fermentative production of ethanol by heterologous expression of a pyruvate decarboxylase gene in bacillus sp |
| 10/11/2001 | WO2001034830A3 Assay of micro-organisms in cell cultures |
| 10/11/2001 | WO2000042429A3 In vitro model for gastrointestinal inflammation |
| 10/11/2001 | WO2000026248A3 Tuberculosis diagnostic test |
| 10/11/2001 | US20010029253 Composition for external application containing a beta-1,6-branched-beta-1,3-glucan |
| 10/11/2001 | US20010029251 Administering cytomegalo virus protein |
| 10/11/2001 | US20010029043 Prokaryotic; transformed with nucleic acid encoding papillomavirus virus major capsid protein that assembles within, such as Salmonella, to form chimeric virus like particles; anticancer, antitumor vaccine |
| 10/11/2001 | US20010029041 Isolated, live, attenuated phenotype useful for stimulating protective immune response without producing severe symptoms; respiratory stress |
| 10/11/2001 | US20010029039 Using culture media and yeast extracts |
| 10/11/2001 | US20010029037 Method for producing halo-L-tryptophan |
| 10/11/2001 | EP1145001A3 (in vitro) model for gastrointestinal inflammation |
| 10/11/2001 | EP1144447A3 Tuberculosis diagnostic test |
| 10/11/2001 | DE10013619A1 New polypeptide subunit of invertebrate ligand-controlled anion channel, useful in screening for potential plant-protection agents, especially insecticides |
| 10/11/2001 | CA2405515A1 Isolation and expression of a gene for a nitrilase from acidovorax facilis 72w |
| 10/11/2001 | CA2404312A1 Chemokine receptor antagonists |
| 10/11/2001 | CA2399399A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
| 10/10/2001 | EP1143010A1 Quantification of paralyzing toxins (psp) by fluorimetry in excitable cells |
| 10/10/2001 | EP1143009A1 Process for producing polypeptide in cell-free protein synthesis system |
| 10/10/2001 | EP1143008A1 Process for producing pyrrole-2-carboxylic acid |
| 10/10/2001 | EP1143004A2 Bacillus thuringiensis microbes active against nematodes, and genes encoding novel nematode-active toxins cloned from bacillus thuringiensis isolates |
| 10/10/2001 | EP1143003A2 Nucleic acid sequences coding for the rplk gene and a process for preparing L-amino acids |
| 10/10/2001 | EP1142998A1 Method of breeding yeast |
| 10/10/2001 | EP1142995A1 Antiuracil monoclonal antibody |
| 10/10/2001 | EP1142994A1 Thermostable creatine amidinohydrolase and process for producing the same |
| 10/10/2001 | EP1142989A2 Chondrocyte cell-lines |
| 10/10/2001 | EP1142987A1 Composition of powdered aureobacidium culture solution, manufacturing method thereof and powder mixture with the composition |
| 10/10/2001 | EP1142986A2 Chanoclavine-producing endophytic fungi of the genus Neotyphodium, and artificially endophyte-infected plants |
| 10/10/2001 | EP1142904A1 Sponge protein hydrolysates and methods of producing the same |
| 10/10/2001 | EP1141397A1 Method of sequence identification |
| 10/10/2001 | EP1141382A1 Prokaryotic system designed to monitor protease activity |
| 10/10/2001 | EP1141373A1 Method for the enantioselective reduction of 3,5-dioxocarboxylic acids, their salts and their esters |
| 10/10/2001 | EP1141372A2 Improved in vivo production of cephalosporins |
| 10/10/2001 | EP1141371A1 Methods for producing polypeptides in aspergillus mutant cells |
| 10/10/2001 | EP1141370A1 Polysaccharides containing alpha-1,4-glucan chains and method for producing same |
| 10/10/2001 | EP1141368A1 Method for producing ascorbic acid intermediates |
| 10/10/2001 | EP1141338A1 Recombinant herpes simplex virus useful for treating neoplastic disease |
| 10/10/2001 | EP1141336A2 Variants of egiii-like cellulase and compositions thereof |